212 related articles for article (PubMed ID: 24983760)
1. In silico analysis of functional single nucleotide polymorphisms in the human TRIM22 gene.
Kelly JN; Barr SD
PLoS One; 2014; 9(7):e101436. PubMed ID: 24983760
[TBL] [Abstract][Full Text] [Related]
2. Ancient and recent adaptive evolution in the antiviral TRIM22 gene: identification of a single-nucleotide polymorphism that impacts TRIM22 function.
Kelly JN; Woods MW; Xhiku S; Barr SD
Hum Mutat; 2014 Sep; 35(9):1072-81. PubMed ID: 24863734
[TBL] [Abstract][Full Text] [Related]
3. B30.2/SPRY domain in tripartite motif-containing 22 is essential for the formation of distinct nuclear bodies.
Sivaramakrishnan G; Sun Y; Rajmohan R; Lin VC
FEBS Lett; 2009 Jun; 583(12):2093-9. PubMed ID: 19481078
[TBL] [Abstract][Full Text] [Related]
4. Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals.
Sawyer SL; Emerman M; Malik HS
PLoS Pathog; 2007 Dec; 3(12):e197. PubMed ID: 18159944
[TBL] [Abstract][Full Text] [Related]
5. Different subcellular localisations of TRIM22 suggest species-specific function.
Herr AM; Dressel R; Walter L
Immunogenetics; 2009 Apr; 61(4):271-80. PubMed ID: 19212762
[TBL] [Abstract][Full Text] [Related]
6. Mutations Conferring Increased Sensitivity to Tripartite Motif 22 Restriction Accumulated Progressively in the Nucleoprotein of Seasonal Influenza A (H1N1) Viruses between 1918 and 2009.
Pagani I; Di Pietro A; Oteiza A; Ghitti M; Mechti N; Naffakh N; Vicenzi E
mSphere; 2018 Apr; 3(2):. PubMed ID: 29624498
[TBL] [Abstract][Full Text] [Related]
7. TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment.
Singh R; Patel V; Mureithi MW; Naranbhai V; Ramsuran D; Tulsi S; Hiramen K; Werner L; Mlisana K; Altfeld M; Luban J; Kasprowicz V; Dheda K; Abdool Karim SS; Ndung'u T
J Virol; 2014 Apr; 88(8):4291-303. PubMed ID: 24478420
[TBL] [Abstract][Full Text] [Related]
8. Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A.
Yang C; Zhao X; Sun D; Yang L; Chong C; Pan Y; Chi X; Gao Y; Wang M; Shi X; Sun H; Lv J; Gao Y; Zhong J; Niu J; Sun B
Cell Mol Immunol; 2016 Jan; 13(1):94-102. PubMed ID: 25683609
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of TRIM5 and TRIM22 polymorphisms on treatment responses in Iranian patients with chronic hepatitis C virus infection.
Mobasheri S; Irani N; Sepahi AA; Sakhaee F; Jamnani FR; Vaziri F; Siadat SD; Fateh A
Gene; 2018 Nov; 676():95-100. PubMed ID: 30017737
[TBL] [Abstract][Full Text] [Related]
10. Tripartite Motif 22 (TRIM22) protein restricts herpes simplex virus 1 by epigenetic silencing of viral immediate-early genes.
Reddi TS; Merkl PE; Lim SY; Letvin NL; Knipe DM
PLoS Pathog; 2021 Feb; 17(2):e1009281. PubMed ID: 33524065
[TBL] [Abstract][Full Text] [Related]
11. Identification of TRIM22 single nucleotide polymorphisms associated with loss of inhibition of HIV-1 transcription and advanced HIV-1 disease.
Ghezzi S; Galli L; Kajaste-Rudnitski A; Turrini F; Marelli S; Toniolo D; Casoli C; Riva A; Poli G; Castagna A; Vicenzi E
AIDS; 2013 Sep; 27(15):2335-44. PubMed ID: 23921607
[TBL] [Abstract][Full Text] [Related]
12. Elevated rate of fixation of endogenous retroviral elements in Haplorhini TRIM5 and TRIM22 genomic sequences: impact on transcriptional regulation.
Diehl WE; Johnson WE; Hunter E
PLoS One; 2013; 8(3):e58532. PubMed ID: 23516500
[TBL] [Abstract][Full Text] [Related]
13. Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease.
Li Q; Lee CH; Peters LA; Mastropaolo LA; Thoeni C; Elkadri A; Schwerd T; Zhu J; Zhang B; Zhao Y; Hao K; Dinarzo A; Hoffman G; Kidd BA; Murchie R; Al Adham Z; Guo C; Kotlarz D; Cutz E; Walters TD; Shouval DS; Curran M; Dobrin R; Brodmerkel C; Snapper SB; Klein C; Brumell JH; Hu M; Nanan R; Snanter-Nanan B; Wong M; Le Deist F; Haddad E; Roifman CM; Deslandres C; Griffiths AM; Gaskin KJ; Uhlig HH; Schadt EE; Muise AM
Gastroenterology; 2016 May; 150(5):1196-1207. PubMed ID: 26836588
[TBL] [Abstract][Full Text] [Related]
14. Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain.
Gao B; Duan Z; Xu W; Xiong S
Hepatology; 2009 Aug; 50(2):424-33. PubMed ID: 19585648
[TBL] [Abstract][Full Text] [Related]
15. TRIM22. A Multitasking Antiviral Factor.
Pagani I; Poli G; Vicenzi E
Cells; 2021 Jul; 10(8):. PubMed ID: 34440633
[TBL] [Abstract][Full Text] [Related]
16. TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation.
Di Pietro A; Kajaste-Rudnitski A; Oteiza A; Nicora L; Towers GJ; Mechti N; Vicenzi E
J Virol; 2013 Apr; 87(8):4523-33. PubMed ID: 23408607
[TBL] [Abstract][Full Text] [Related]
17. The interferon response inhibits HIV particle production by induction of TRIM22.
Barr SD; Smiley JR; Bushman FD
PLoS Pathog; 2008 Feb; 4(2):e1000007. PubMed ID: 18389079
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide scan in two groups of HIV-infected patients treated with dendritic cell-based immunotherapy.
Moura Rodrigues R; Plana M; Garcia F; Zupin L; Kuhn L; Crovella S
Immunol Res; 2016 Dec; 64(5-6):1207-1215. PubMed ID: 27704462
[TBL] [Abstract][Full Text] [Related]
19. In silico Analysis Revealed High-risk Single Nucleotide Polymorphisms in Human Pentraxin-3 Gene and their Impact on Innate Immune Response against Microbial Pathogens.
Thakur R; Shankar J
Front Microbiol; 2016; 7():192. PubMed ID: 26941719
[TBL] [Abstract][Full Text] [Related]
20. Identification of TRIM22 as a RING finger E3 ubiquitin ligase.
Duan Z; Gao B; Xu W; Xiong S
Biochem Biophys Res Commun; 2008 Sep; 374(3):502-6. PubMed ID: 18656448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]